25 results
424B5
IMPLQ
Impel Pharmaceuticals Inc
5 Oct 23
Prospectus supplement for primary offering
5:19pm
if any product we develop allegedly causes injury or is found to be otherwise unsuitable during product testing, manufacturing, marketing or sale. Any … financial and management resources.
Regardless of the merits or eventual outcome, liability claims may result in:
injury to our reputation
8-K
EX-10.4
IMPLQ
Impel Pharmaceuticals Inc
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
, physical injury, emotional distress, claims for additional compensation or benefits arising out of your employment or your separation or resignation
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
Material or any actual or alleged Hazardous Materials Activity; or (iii) in connection with any actual or alleged damage, injury, threat or harm
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
with any Hazardous Material or any actual or alleged Hazardous Materials Activity; or (iii) in connection with any actual or alleged damage, injury
10-K
gq42ff
29 Mar 22
Annual report
5:09pm
424B4
kn8v2ksgfhdg333
10 Sep 21
Prospectus supplement with pricing info
4:01pm
DRS
2f4kh366ta
25 Aug 21
Draft registration statement
12:00am
10-Q
byueq2br9h nx443
7 Jun 21
Quarterly report
7:17am
424B1
27apfibxe11sd efs
23 Apr 21
Prospectus with pricing info
4:01pm